July 17, 2025

Cipla, a renowned pharmaceutical company, has once again emphasized its dedication to delivering high-quality and cost-effective products, with a specific focus on respiratory and obesity treatments. YK Hamied, the company's top official, reiterated the significance of these therapeutic areas during a recent address. With a legacy of 90 years, Cipla continues to prioritize the development and distribution of medicines that address crucial health needs. By underscoring its commitment to affordability and excellence, the company aims to enhance access to crucial treatments for respiratory issues and obesity, two prevalent health concerns globally. The reaffirmation of these focus areas underscores Cipla's ongoing efforts to make a positive impact on public health by ensuring the availability of effective medications at reasonable prices. Through strategic initiatives and continuous innovation, Cipla remains steadfast in its mission to improve the quality of life for patients worldwide.

Read More at Thehindubusinessline →

Tags: Cipla, Healthcare, Pharmaceuticals,